Articles From: Anglo Pacific Group PLC Publication of Prospectus and Circular and Launch of Open Offer to Anixter International Inc. to Sell Its Fasteners Segment to American Industrial Partners for $380 Million


2015/2/6
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC Publication of Prospectus and Circular and Launch of Open Offer investment picks
2014/12/9
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: Director's Share Dealings investment picks
2015/2/26
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: Results of General Meeting investment picks
2015/2/17
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: TR-1: Notification of Major Interest in Shares investment picks
2015/2/13
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: TR-1: Notification of Major Interest in Shares investment picks
2015/2/12
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: TR-1: Notification of Major Interest in Shares investment picks
2015/2/13
By Ian Walker And Scott Patterson LONDON--
Sign-up for Anglo Reports Another Net Loss on Write-Downs investment picks
2015/2/13
By Ian Walker And Scott Patterson LONDON--
Sign-up for Anglo Reports Another Net Loss on Write-Downs--Update investment picks
2015/2/10
By Alexandra Wexler CAPE TOWN--AngloGold Ashanti (AU), the world's third-largest gold producer, is still considering a joint operation or sale of an asset for full value to help reduce debt, the firm's chief executive, Srinivasan Venkatakrishnan, told the Indaba mining conference in Cape Town on Tuesday.
Sign-up for AngloGold Ashanti Still Considering Asset Sales, Joint Ventures investment picks
2015/2/23
http://www.marketwire.com/library/MwGo/2015/2/23/11G033796/AngloGold_Ashanti-1123520250393.jpg JOHANNESBURG, SOUTH AFRICA--(Marketwired - February 23, 2015) - AngloGold Ashanti (NYSE: AU) today posted its second consecutive growth in annual production alongside a 13% improvement in all-in sustaining costs, as it continued to focus on portfolio improvements and capital discipline.
Sign-up for AngloGold Output Rises for 2nd Straight Year; Costs Fall 13% investment picks
2015/2/26
By Matthew Dalton BRUSSELS --
Sign-up for Anheuser Busch InBev Fourth-Quarter Profit Rises on Stronger U.S. Sales investment picks
2015/2/26
BRUSSELS -- Anheuser Busch InBev (ABI.BT) on Thursday reported its net profit inched up in the fourth quarter, as stronger performance in the U.S. helped offset the impact of a stronger dollar.
Sign-up for Anheuser Busch Lifted by Stronger U.S. Sales investment picks
2015/2/26
By Matthew Dalton BRUSSELS--Anheuser Busch InBev on Thursday reported its net profit inched up in the fourth quarter, as economic recovery in the U.S. helped offset the impact of a stronger dollar that hurt sales elsewhere in the company's global beer empire.
Sign-up for Anheuser Busch Profit Rises investment picks
2015/2/24
FRANKFURT--The following is a summary of analysts' forecasts for Anheuser-Busch InBev (ABI.BT) fourth-quarter results, based on a poll of eight analysts conducted by Dow Jones Newswires (figures in million dollars, EPS and dividend in dollar, target price in euro, according to IFRS). Earnings figures are scheduled to be released February 26.
Sign-up for Anheuser-Busch InBev 4Q 2014 -- Forecast investment picks
2015/2/12
Why A-B would want them: Because every brewer worth their beer wants to be in Asheville.
Sign-up for Anheuser-Busch should buy these craft beer -2- investment picks
2015/2/12
By Jason Notte, MarketWatch The conglomerate has been on a buying spree as craft takes market share Start your breathing exercises and pick your mantras now, craft beer groupies: Anheuser-Busch InBev is going to buy another brewery.
Sign-up for Anheuser-Busch should buy these craft beer brewers next investment picks
2015/2/3
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces Appointment of Dr. David Sullivan to VP of Quality Operations investment picks
2014/12/5
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering investment picks
2015/1/30
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces the Launch of Etodolac 300mg Capsules investment picks
2014/12/11
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference investment picks
2015/2/19
For the fourth quarter 2014: - Record net revenues of $21.0 million, an increase of 100% over fourth quarter 2013 - Record adjusted non-GAAP EBITDA of $12.8 million, an increase of 225% over fourth quarter 2013 - Adjusted non-GAAP diluted earnings per share of $1.94, which includes the positive impact of a $16.7 million deferred tax valuation allowance reversal For the full year ended December 31, 2014: - Record annual revenues of $56.0 million, an increase of 86% over 2013 - Record adjusted non-GAAP EBITDA of $27.3 million, an increase of 264% over 2013 - Adjusted non-GAAP diluted earnings per share of $2.96, which includes the positive impact of a $16.7 million deferred tax valuation allowance reversal BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/12
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2014 Financial Results investment picks
2014/12/4
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes investment picks
2015/2/12
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2014 financial results after the close of the market on Wednesday, February 25, 2015.
Sign-up for Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2014 Financial Results Conference Call investment picks
2015/2/11
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (HA) technology, today announced that it has filed regulatory submissions in both the United States and Europe seeking the approval of Cingal, the Company’s novel HA plus steroid single-injection treatment for osteoarthritis of the knee.
Sign-up for Anika Therapeutics Announces Regulatory Submissions with U.S. FDA and European Regulatory Authorities for Cingal® investment picks
2015/2/19
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has appointed Glenn R.
Sign-up for Anika Therapeutics Appoints Dr. Glenn Larsen to its Board of Directors investment picks
2015/2/25
Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today reported financial results for the quarter and full year ended December 31, 2014.
Sign-up for Anika Therapeutics Reports Fourth-Quarter and Full-Year 2014 Financial Results investment picks
2015/2/3
Anixter International Inc. (NYSE: AXE) today reported sales of $1.67 billion for the quarter ended January 2, 2015, a 4.4 percent increase compared to the year-ago quarter.
Sign-up for Anixter International Inc. Reports Fourth Quarter 2014 Results investment picks
2015/2/12
Anixter International Inc. (NYSE: AXE) today announced that it has entered into a definitive agreement to sell its OEM Supply – Fasteners (“Fasteners”) segment to American Industrial Partners (“AIP”) for $380 million in cash, subject to certain post-closing adjustments.
Sign-up for Anixter International Inc. to Sell Its Fasteners Segment to American Industrial Partners for $380 Million investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Anglo Pacific Group PLC Publication of Prospectus and Circular and Launch of Open Offer to Anixter International Inc. to Sell Its Fasteners Segment to American Industrial Partners for $380 Million
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent